Provided by Tiger Trade Technology Pte. Ltd.

Veru Inc.

2.09
-0.1400-6.28%
Volume:80.17K
Turnover:170.17K
Market Cap:33.55M
PE:-1.76
High:2.28
Open:2.23
Low:2.06
Close:2.23
52wk High:7.40
52wk Low:2.06
Shares:16.05M
Float Shares:14.48M
Volume Ratio:1.73
T/O Rate:0.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1898
EPS(LYR):-1.5517
ROE:-60.25%
ROA:-42.92%
PB:0.90
PE(LYR):-1.35

Loading ...

Veru Inc - FY Net Loss From Cont Ops Decreased to $15.7 Mln or $1.07 per Share

THOMSON REUTERS
·
Dec 17, 2025

Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress

THOMSON REUTERS
·
Dec 17, 2025

Veru Inc - Received FDA Regulatory Clarity for Enobosarm in Combination With Glp-1 Ra

THOMSON REUTERS
·
Dec 17, 2025

Top Wall Street Forecasters Revamp Veru Expectations Ahead Of Q4 Earnings

Benzinga
·
Dec 16, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Dec 15, 2025

Veru Inc. to Announce Fiscal Year 2025 Financial Results

Reuters
·
Dec 10, 2025

Veru to Report Fiscal Year 2025 Financial Results on December 17th

GlobeNewswire
·
Dec 10, 2025

Veru to Present at The Society on Sarcopenia, Cachexia, and Wasting Disorders 18th International Conference and Regulatory and Clinical Trials Update Regulatory Workshop

GlobeNewswire
·
Dec 04, 2025

Veru Inc. unveils pipeline targeting obesity and cardiometabolic disease with novel drug combinations

Reuters
·
Nov 20, 2025

Veru to Present Two Abstracts at ObesityWeek 2025

GlobeNewswire
·
Oct 31, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Fiserv, CMS Energy, Moderna

Reuters
·
Oct 31, 2025

BUZZ-Biopharma firm Veru tumbles on $25 mln stock-and-warrants offering

Reuters
·
Oct 30, 2025

Veru Inc - Proceeds to Fund Enobosarm Phase 2B Study

THOMSON REUTERS
·
Oct 30, 2025

Veru Announces Pricing of $25 Million Public Offering

THOMSON REUTERS
·
Oct 30, 2025

Veru Inc - Combined Offering Price Accompanying Series a Warrant & Accompanying Series B Warrant Is $3.00 per Share

THOMSON REUTERS
·
Oct 30, 2025

Veru announces offering of common stock and warrants, no amount given

TIPRANKS
·
Oct 30, 2025

Press Release: Veru Announces Proposed Public Offering

Dow Jones
·
Oct 30, 2025

Veru Inc. Completes Promising Phase 2 Study on Enobosarm for Weight Management

TIPRANKS
·
Oct 28, 2025

Veru Inc. Unveils New Presentation Highlighting Obesity Drug Pipeline and Muscle Preservation Strategy

Reuters
·
Oct 17, 2025

Trump Excludes Generics From Big Pharma Tariff Plan

Dow Jones
·
Oct 09, 2025